Skip to main content

HQL · abrdn Life Sciences Investors · Executive Compensation

Track HQL — free
$18.00 +0.30 (+1.69%) At close · Oct 27
Market Cap
$547.34M
Shares
30.41M
Volume · Oct 27 166.85K Avg daily vol (3M) 137.57K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Leadership

Key facts CIK 884121 CUSIP 87911K100 13F (30d) 19 filings 19 filers Investor relations